Survival from breast cancer in women with a BRCA2 mutation by treatment.

D Gareth EvansKelly-Anne PhillipsRoger L MilneRobert FruscioCezary CybulskiJacek GronwaldJan LubinskiTomasz HuzarskiZerin HyderClaire FordeKelly MetcalfeLeigha SenterJeffrey WeitzelNadine TungDana ZakalikMaria EkholmPing SunSteven A Narodnull null

Published in: British journal of cancer (2021)

For women with breast cancer and a germline BRCA2 mutation, positive ER status does not predict superior survival. Oophorectomy is associated with a reduced risk of death from breast cancer and should be considered in the treatment plan.

Keyphrases

breast cancer risk
dna repair
combination therapy
estrogen receptor
breast cancer cells
smoking cessation